Consensus Copart, Inc.

Stocks

CPRT

US2172041061

Internet Services

Market Closed - Nasdaq Other stock markets 01:30:00 31/07/2026 am IST			After hours 05:30:00 am
29.56 ^USD	-4.07%		29.45	-0.39%

01:38pm	Copart Insider Sold Shares Worth $845,945, According to a Recent SEC Filing	MT
21/07	Barclays Adjusts Price Target on Copart to $26 From $32, Maintains Underweight Rating	MT

Evolution of the Average Target: Copart, Inc.

Evolution of the Target Price: Copart, Inc.

Changes in Analyst Recommendations: Copart, Inc.

d088065b73d202fca6d49f0c3d7.GmJNfynvmeQApI46zchGYsGP3VGeOW8tZAIBmh8hTew.KlQXFmu519BEztwOgf0CBruilQ78cj8UEktvrFoZHZlUVi8eHK7R10LP2w~c627058967a71ac8c69be1d9cf91319d

Analysts' recommendations: Copart, Inc.

21/07	Barclays Adjusts Price Target on Copart to $26 From $32, Maintains Underweight Rating	MT
07/07	JPMorgan Adjusts Price Target on Copart to $32 From $35	MT
26/05	Stephens Adjusts Copart Price Target to $35 From $33, Maintains Equal Weight Rating	MT
22/05	BNP Paribas Adjusts Copart Price Target to $40 From $44, Maintains Outperform Rating	MT
22/05	Baird Adjusts Price Target on Copart to $42 From $48, Maintains Outperform Rating	MT
22/05	JPMorgan Adjusts Price Target on Copart to $35 From $34, Maintains Neutral Rating	MT
15/05	Stephens Adjusts Copart Price Target to $33 From $35, Maintains Equal Weight Rating	MT
23/02	JPMorgan Adjusts Price Target on Copart to $34 From $45, Maintains Neutral Rating	MT
20/02	Jefferies Adjusts Price Target on Copart to $47 From $50, Maintains Buy Rating	MT
20/02	Baird Adjusts Price Target on Copart to $48 From $52, Maintains Outperform Rating	MT
20/02	BNP Paribas Adjusts Price Target on Copart to $44 From $47, Maintains Outperform Rating	MT
20/02	Barclays Adjusts Price Target on Copart to $32 From $33, Maintains Underweight Rating	MT
18/12	BMO Keeps RB Global's Outperform Rating, US$130 Price Target	MT
02/12	Stephens Adjusts Price Target on Copart to $39 From $46, Maintains Equalweight Rating	MT
24/11	JPMorgan Adjusts Price Target on Copart to $45 From $50, Maintains Neutral Rating	MT
21/11	BNP Paribas Exane Adjusts Price Target on Copart to $47 From $58	MT
21/11	Baird Adjusts Price Target on Copart to $52 From $55, Maintains Outperform Rating	MT
21/11	Barclays Adjusts Price Target on Copart to $33 From $32, Maintains Underweight Rating	MT
12/11	Barclays Initiates Copart at Underweight With $32 Price Target	MT
05/25/05	Stephens Adjusts Copart Price Target to $46 From $50, Maintains Equal Weight Rating	MT
05/25/05	JPMorgan Adjusts Copart Price Target to $50 From $55, Maintains Neutral Rating	MT
05/25/05	BNP Paribas Exane Adjusts Copart Price Target to $58 From $66, Maintains Outperform Rating	MT
05/25/05	Copart Shares Rise After Upgrade From HSBC	MT
04/25/04	Analyst recommendations: Copart, Leidos Holdings, Parker-Hannifin, Workday, Macy's…
04/25/04	HSBC Upgrades Copart to Buy From Hold, Adjusts Price Target to $62 From $56	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	COPART, INC.					+36.31%
	ALIBABA GROUP HOLDING LIMITED					+62.72%
	SHOPIFY INC.					+21.3%
	PDD HOLDINGS INC.					+32.69%
	MERCADOLIBRE, INC.					+17.45%
	MEITUAN					+16.61%
	EBAY INC.					-1.94%
	VIPSHOP HOLDINGS LIMITED					+20.19%
	GLOBAL-E ONLINE LTD.					+16.34%
	USS CO., LTD.					+1.02%
	Average					+22.27%
	Weighted average by Cap.					+34.52%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

29.56USD

Average target price

40.30USD

Spread / Average Target

+36.31%

High Price Target

55.00USD

Spread / Highest target

+86.03%

Low Price Target

26.00USD

Spread / Lowest Target

-12.06%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barclays
JPMorgan Chase
Stephens Inc.
BNP Paribas
Baird
Jefferies & Co.
BNP Paribas Exane
HSBC
Argus
CJS Securities
Northcoast Research
Guggenheim
Truist Securities
Exane BNP Paribas